Načítá se...
Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations
INTRODUCTION: COPD places a huge clinical and economic burden on the US health care system, with acute exacerbations representing a key driver of direct medical costs. Current treatments, although effective in reducing symptoms and limiting exacerbations, do not adequately target the underlying dise...
Uloženo v:
| Vydáno v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5655131/ https://ncbi.nlm.nih.gov/pubmed/29089755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S143334 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|